Showing results (201-210 of 277) with videos related to
Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Initial Chemotherapy for Locally Advanced and Metastatic NUT CarcinomaJia Luo, Michelle Sanchez, Elinton Lee, et al.Gynecologic Oncology|October 4, 2021
Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancerElizabeth M Swisher, Rebecca S Kristeleit, Amit M Oza, et al.Molecular Cancer Therapeutics|October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic CancerRyan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapyThomas J Lynch, George R Blumenschein, Jeffrey A Engelman, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2012
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancerOddbjørn Straume, Takeshi Shimamura, Michael J G Lampa, et al.Nature Medicine|January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W Clark, Jared Weiss, et al.Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast CancerTanya E Keenan, Tianyu Li, Tuulia Vallius, et al.JCO Precision Oncology|April 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker AnalysesPanagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, et al.Pageof 28